Prior research indicated that patients with lung cancer who underwent treatment with PD-1 blockade experienced respiratory distress, with subsequent PET-CT examinations revealing thickening and abnormal FDG uptake in the tracheobronchial and nasal septum cartilage, ultimately leading to a diagnosis of RP (12). This evidence concerns the gene PDCD1 and lung cancer.